U.S. health officials recommend re-use of the corona virus vaccine Johnson & Johnson, Maybe it is Weekend, One in an ad New warning about rare blood clotting problem, But it has been reported that there will be no age limits Washington Post.
In this way, the level will be Similar to that accepted by the European Pharmaceuticals Company, This week Johnson & Johnson said the vaccine should go with one Warning, Though Does not impose restrictions on its use. The company promised it Its benefits outweigh the risks.
The current position of U.S. officials was released by two government officials who spoke anonymously with the Washington Post. They said Reports of blood clots may be caused by sudden flooding, which is not possible, or other surprises related to the vaccine.
It is hoped that the final decision on Johnson & Johnson’s vaccine will be publicly discussed at a meeting this Friday, in which an influencer will take part. Advisory Board for Centers for Disease Control and Prevention (CDC).
This group of independent experts, The Advisory Committee on Immunization Procedures, Last met on April 14th. At the time, he was reviewing a decision made the previous day by the CDC and the Food and Drug Administration (FDA). Six cases of severe cerebral palsy among more than 7.5 million vaccinated people. The committee said at the meeting that it was needed Additional data before recommending a restart or other actionSuch as restrictions based on age or gender.
CDC and FDA officials declined to comment on whether federal officials would like to recommend the suspension in response to The Washington Post’s inquiries. Executive Commissioner of the FDA, Janet Woodcock, Said this Thursday I do not want to “cover up” the discussions of the advisory board CDC When Rochelle Valensky, The CDC director said Wednesday You don’t want to progress beyond the group’s decision.
Anyway, they both shared Promoting data on freezing events. Valensky said the government has only got one Additional cases “handle”, Adding that “many more are to be delivered” and that the final number will be given on Friday. But he promised it A large number of people would not say they are suffering from tumors.
In the same way, Woodcock said officers The “biggest avalanche” of freezing cases was not observed. “This is a huge relief,” he said.
The rarity of cases has been reported in several U.S. The problem can be solved by adding warnings that describe groups at risk of adverse effects, And work to make sure doctors know how to diagnose and treat the problem. In particular, health professionals are advised to avoid use Heparin, Is a common treatment for thrombosis because it can worsen the vaccine-related condition.
If the CDC Advisory Council votes Friday to end Johnson & Johnson’s vaccination suspension, the CDC and FDA may recommend re-injection. Hours or days matter. That decision would be good news for many state officials to start using the vaccine again. Single dose. But still If the advisory board has a different opinion and recommends that the vaccine should not be used by certain age groups or anyone, it is not yet clear what will happen next..